generics

FDA Approves First Generic Naloxone Nasal Spray for Opioid Overdose Treatment
RAPS.org
Fri, 04/19/19 - 06:22 pm
Teva Pharmaceutical
FDA
generics
Naloxone
Narcan
opioid overdose
United Therapeutics Fires Back After Sandoz Files Anti-Competitive Lawsuit Over PAH Drug
BioSpace
Fri, 04/19/19 - 05:53 pm
United Therapeutics
PAH
Remodulin
generics
Sandoz
Akorn Inc. Scores Two Generic Approvals from the FDA
BioSpace
Fri, 04/19/19 - 10:40 am
Akorn
FDA
generics
Flonase
GSK
Lotemax
Bausch + Lomb
Generics would get a new boost from bipartisan bills
BioCentury
Sat, 04/13/19 - 12:04 pm
Senate
generics
biosimilars
competition
legislation
Pfizer, AstraZeneca and J&J Take Issue With FDA’s List of Companies Withholding Drug Samples
RAPS.org
Fri, 04/12/19 - 11:46 pm
generics
Pfizer
AstraZeneca
JNJ
Wockhardt receives US FDA approval for cancer drug
Pharmaceutical Business Review
Fri, 04/12/19 - 10:09 am
Wockhardt
decitabine
FDA
generics
Otsuka
Dacogen
myelodysplastic syndromes
Gilead cuts cardiopulmonary sales reps
BioCentury
Wed, 04/10/19 - 11:44 pm
Gilead Sciences
layoffs
generics
Letairis
Ranexa
Manufacturing problems persist for Aurobindo, U.S.' second-largest generics producer
Fierce Pharma
Tue, 04/9/19 - 10:18 pm
Aurobindo
generics
Novartis
drug manufacturing
After Apotex founder's murder, family weighs sale worth up to $3B: report
Fierce Pharma
Fri, 04/5/19 - 11:34 pm
Apotex
generics
Barry Sherman
M&A
AARP report offers window into generic drugmaker pain
Biopharma Dive
Fri, 04/5/19 - 10:29 am
drug pricing
retail pricing
generics
AARP
Medicaid misclassification bill inspired by EpiPen snafu passes Congress
Fierce Pharma
Wed, 04/3/19 - 12:24 pm
Mylan
generics
EpiPen
Medicaid
congress
misclassification
After Alzheimer’s collapse, Biogen must win Tecfidera patent challenge
EP Vantage
Mon, 03/25/19 - 11:57 am
Biogen
Alzheimer's disease
Tecfidera
generics
Mylan
Behind the Numbers: FDA Offers Budget Specifics, New Proposals
RAPS.org
Mon, 03/18/19 - 11:46 pm
FDA
opioid crisis
generics
devices
FDA approves valsartan generic amid probe into impurities
Biopharma Dive
Fri, 03/15/19 - 09:18 am
FDA
hypertension
generics
Valsartan
CEO of Novartis’ generics unit quits, sparking sale speculation
Pharmaforum
Thu, 03/14/19 - 10:06 am
Novartis
Sandoz
generics
M&A
Richard Francis
biosimilars
Trump’s 2020 Budget Seeks FDA Tweaks to Increase Generic Competition
RAPS.org
Mon, 03/11/19 - 10:18 pm
Donald Trump
competition
FDA
generics
Mylan's Advair generic pressures GSK with strong launch
BioPharma Dive
Fri, 03/8/19 - 04:09 pm
GSK
Mylan
generics
Advair
Wixela Inhub
Teva launches generic for Pfizer’s Flector pain patch
Drug Delivery Business News
Mon, 03/4/19 - 07:31 pm
Teva Pharmaceutical
generics
Pfizer
Flector
pain patches
2018 in Generic Drugs: Approvals Shine but Questions Remain on Competition
RAPS.org
Sat, 03/2/19 - 12:46 pm
generics
Additional exclusivity for a cancer treatment could cost the public $3 billion, analyst says
Endpoints
Mon, 02/25/19 - 11:32 pm
FDA
Eagle Pharmaceuticals
Treanda
generics

Pages